has been acquired by
for a minimum of $68M plus
potential aeronaut milestones
for a minimum of $68M plus
potential aeronaut milestones
Selected Transactions
has been acquired by
$25,000,000
Series C Financing
$11,635,896.05
has been acquired by
has been acquired by
has acquired
has acquired
Aevi Genomic Medicine, Inc.
$15.6M plus contingent
value rights up to $6.5M
Aevi Genomic Medicine, Inc.
$15.6M plus contingent
value rights up to $6.5M
has been acquired by
has acquired
has been acquired by 
has acquired
Series Seed Preferred
Stock Financing
$5,000,000
has merged with
has acquired
Private Placement of
Subordinated Notes
Subordinated Notes
$12,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has been acquired by
Thoroughbred Capital LLC
has acquired
Diabetic Health, Inc.
(f/k/a Clinical Sensors, Inc.)
a division of Greenwich Associates
was acquired by
a portfolio company of
was acquired by
a portfolio company of
Series C Preferred
Stock Financing
Private Placement of
Fixed-to-Floating
Subordinated Notes
Due Dec 2029
$32,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
Series C Preferred Stock Financing
for NoHo Health, Inc.
US$25,000,000
Collaboration Agreement
with
Genective S.A.
Series B Investment
in eGenesis Bio
US$50,000,000
Pediatric Portfolio
has been acquired by
$43,000,000
has been acquired by
$43,000,000
has been acquired by
a portfolio company of
a portfolio company of
Private Placement of
Subordinated Notes
Subordinated Notes
$10,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has acquired
has been acquired by
Public Offering
of Common Stock
$14,000,000
$3,500,000
Class A Preferred Units
has been acquired by
Raptor Technologies, LLC
De Novo Formation and
Initial Public Offering
$22,500,000
Lead Book-Running Manager
in the $31,050,000 IPO for
$5,300,000
Public Offering
Series A Financing
$8,000,000
has been acquired by
Common Stock Offering
$10,000,000
Secondary Public Offering
$316,542,774
Private Placement of Mandatory
Convertible Subordinated Notes
Convertible Subordinated Notes
$18,550,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
Private Placement of
Common Stock and
Convertible Preferred Stock
Common Stock and
Convertible Preferred Stock
$15,200,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has acquired
has acquired
Novum Pharmaceutical
Research Services
Follow-on Public Offering
of Common Stock
$3,400,000
$240,000,000
Rule 144A Offering of
1.25% Convertible Senior Notes
Due 2023
has been acquired by
has been acquired by
Waste Industries
has merged with
US$2.825 billion
US$2.825 billion
has merged with
has acquired
Follow-on Public Offering
of Common Stock
$63,250,008
Secondary Public Offering
$298,380,000
Waste Industries
has acquired the assets of
Lebanon Farms Disposal, Inc.
(Pennsylvania)
(Pennsylvania)
has merged with
Receivables Securitization
Financing
$250,000,000
Series A Financing
Up to $6 Million
has received a
growth equity investment from
Eli Lilly and Company
has acquired
AurKa Pharma, Inc.
$110,000,000 plus
up to $465,000,000
in regulatory and sales
milestones
Private Placement
of Common Stock
of Common Stock
$11,643,750
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
Waste Industries
has acquired
has acquired
a majority interest in
Follow-on Public Offering
of Common Stock
$19,968,000
has acquired the assets of
has acquired
has been acquired by
Series A Financing
$4,600,000
Common Stock
Rights Offering
Rights Offering
$12,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has acquired
Private Placement
of Common Stock
of Common Stock
$30,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
Series A Financing
$4,500,000
has acquired
has acquired
certain assets from
has acquired
has merged with
Private Placement
of Common Stock
of Common Stock
$8,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has been acquired by
Press Ganey Associates
has acquired
License and
Development Agreement
has acquired
has been acquired by